Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2026 | Q4 | $198.5M | -- | -- | $1.21 | -- |
| 11/04/2025 | Q3 | $184.5M | $184.6M | $0.73 | $1.05 | -$0.32 |
| 08/05/2025 | Q2 | $144.2M | $142.2M | $0.64 | $0.77 | -$0.13 |
| 05/05/2025 | Q1 | $121.1M | $133.1M | $0.85 | $0.43 | $0.42 |
| 03/11/2025 | Q4 | $149.4M | $143.7M | $0.82 | $0.77 | $0.05 |
| 11/05/2024 | Q3 | $129.5M | $133.9M | $0.62 | $0.46 | $0.16 |
| 08/06/2024 | Q2 | $122.7M | $122.2M | $0.50 | $0.37 | $0.13 |
| 05/09/2024 | Q1 | $122.3M | $119M | $0.64 | $0.32 | $0.32 |
| 03/13/2024 | Q4 | $129.4M | $142.7M | $0.44 | $0.40 | $0.04 |
| 11/08/2023 | Q3 | -- | $127.8M | $0.61 | -- | -- |
| 08/09/2023 | Q2 | -- | $124.9M | $0.46 | -- | -- |
| 05/08/2023 | Q1 | -- | $121M | $0.27 | -- | -- |
| 03/08/2023 | Q4 | -- | $143.5M | $0.35 | -- | -- |
| 11/09/2022 | Q3 | -- | $122.4M | $0.34 | -- | -- |
| 08/09/2022 | Q2 | -- | $116.1M | $0.08 | -- | -- |
| 05/10/2022 | Q1 | -- | $114.8M | -$0.15 | -- | -- |
| 03/16/2022 | Q4 | -- | $126.8M | $0.41 | -- | -- |
| 11/10/2021 | Q3 | -- | $129.2M | $0.38 | -- | -- |
| 08/12/2021 | Q2 | -- | $121M | $0.07 | -- | -- |
| 05/14/2021 | Q1 | -- | $113.3M | -$0.25 | -- | -- |
| 03/25/2021 | Q4 | -- | $130.4M | $0.05 | -- | -- |
| 11/12/2020 | Q3 | -- | $163.9M | $0.31 | -- | -- |
| 08/13/2020 | Q2 | -- | $135.2M | $0.37 | -- | -- |
| 05/12/2020 | Q1 | -- | $138.8M | -$0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | $138.9M | $0.13 | -- | -- |
| 11/14/2019 | Q3 | -- | $148.1M | -$0.39 | -- | -- |
| 08/14/2019 | Q2 | -- | $132.6M | -$0.17 | -- | -- |
| 04/16/2019 | Q1 | -- | $133.7M | $0.24 | -- | -- |
| 12/31/2018 | Q4 | -- | $151.4M | $0.44 | -- | -- |
| 11/19/2018 | Q3 | -- | $135.1M | -$0.46 | -- | -- |
| 08/15/2018 | Q2 | -- | $139.5M | $0.09 | -- | -- |
| 04/02/2018 | Q1 | -- | $120.5M | -$0.60 | -- | -- |
| 12/31/2017 | Q4 | -- | $131.4M | $0.12 | -- | -- |
| 11/14/2017 | Q3 | -- | $121.3M | -$0.12 | -- | -- |
| 08/15/2017 | Q2 | -- | $117.8M | $0.05 | -- | -- |
| 03/31/2017 | Q1 | -- | $115.2M | -$0.19 | -- | -- |
| 12/31/2016 | Q4 | -- | $133.7M | -$0.45 | -- | -- |
| 09/30/2016 | Q3 | -- | $118.8M | $0.12 | -- | -- |
| 06/30/2016 | Q2 | -- | $96.6M | -$0.30 | -- | -- |
| 03/31/2016 | Q1 | -- | $97.8M | -- | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
Limbach Holdings, Inc. reported $184.6M worth of top line sales in its most recent quarter.
Limbach Holdings, Inc. announced earnings per share of $0.73 which represents a miss of analyst forecast a $1.05 per share.
Limbach Holdings, Inc. reported $42.3M that represents $3.49 per share over the last quarter.
Limbach Holdings, Inc.'s earnings are forecast to grow from $2.57 per share to $2.59 per share next year representing an increase of 59.71%.
Limbach Holdings, Inc.'s next earnings date is March 10, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.